Keywords: octoplus, begins, dosing, locteron, study, nv, dutch

OctoPlus begins dosing in US Locteron study

Article | 11 February 2008

Print This

OctoPlus NV, a Dutch drug delivery and development company, has begun dosing patients in a US Phase IIa trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in